250 Participants Needed

Pleasant Odors for Craving

(OdorCrave Trial)

MN
MA
Overseen ByMichael A Sayette, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The proposed study uses fMRI and behavioral measures in and outside the laboratory to investigate the neurobehavioral mechanisms underlying the impact of pleasant olfactory cues (OCs) on cigarette craving. The investigators plan to randomize 278 participants to a pleasant OC condition or an odor blank (neutral) condition and due to anticipated drop out expect to run 250 adult (half female) smokers, including both daily and nondaily smokers through the protocol. This study involves three visits. In the first visit, participants will complete a baseline breath carbon monoxide reading, a brief odor threshold test, and complete a series of self-report measures. In the next session, participants who are 8-hrs deprived of nicotine will undergo a 60-minute fMRI scan that will include structural, resting state, and task-based data collection. The fMRI task involves completing a series of tasks designed to index responses linked to key neural networks found to relate to addiction (e.g., reward processing, working memory). Participants will also be exposed to smoking cues to heighten craving and then depending on their condition (randomly assigned) will either receive a pleasant or neutral (odor blank) OC. In the third session, behavioral data will be collected to test the impact of either a pleasant or neutral OC on cigarette craving using self-reported urge and behavioral measures linked to craving. Finally, for pilot purposes designed to offer data for a subsequent clinical study (beyond this study), participants will additionally complete a 7-day ecological momentary assessment (EMA) protocol in which they will monitor cigarette craving and initial data will be collected outside the laboratory to evaluate the impact of OCs on naturally occurring craving. It is hypothesized that pleasant OCs will disrupt craving brain states and attenuate craving (as compared to neutral olfactory cues). Further, it is hypothesized that individual variation in neural responses to cognitive and affective tasks will reveal variation in mechanisms underlying pleasant OC craving reduction and that individual differences will moderate pleasant OC-induced craving relief. Finally, it is also expected that emotional responses to pleasant OCs will mediate the impact of OCs on craving and smoking-related processes.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it does exclude those with current psychoactive drug use and drug dependence outside of nicotine or caffeine.

What data supports the effectiveness of the treatment Pleasant Odors for Craving?

Research shows that pleasant smells can help reduce cravings, such as cigarette cravings, by providing a positive sensory experience that distracts from the urge. In one study, smokers who smelled pleasant odors reported less craving compared to those exposed to neutral or tobacco-related smells.12345

Is it safe to use pleasant odors for reducing cravings?

The research does not provide specific safety data on using pleasant odors for reducing cravings, but studies on pleasant odors generally suggest they can improve mood and reduce hunger without reported adverse effects.46789

How does the Pleasant Odor treatment differ from other treatments for cravings?

The Pleasant Odor treatment is unique because it uses pleasant smells to reduce food cravings by engaging the brain's limited-capacity resources, which is different from traditional methods that might involve medication or dietary changes. This approach leverages the brain's response to pleasant scents to curb cravings, offering a non-invasive and sensory-based alternative.910111213

Research Team

MN

Marc N Coutanche, PhD

Principal Investigator

The University of Pittsburgh

MA

Michael A Sayette, PhD

Principal Investigator

The University of Pittsburgh

Eligibility Criteria

This trial is for right-handed, English-speaking adults aged 18-49 who smoke cigarettes daily (10-30 per day) or nondaily. They must weigh less than 250lbs to fit in an MRI machine safely, have a working smartphone, and an intact sense of smell. Smokers with extreme habits or other drug dependencies besides nicotine or caffeine are excluded.

Inclusion Criteria

Fluent in English
No drug dependence outside of nicotine or caffeine
I weigh 250lbs or less and can safely undergo an MRI.
See 4 more

Exclusion Criteria

Individuals will also be excluded if they report any allergies to the odors used in our study
Baseline CO readings will need to be consistent with our criteria for daily and nondaily smokers for participants to be considered eligible. Specifically, we plan to rule out extremely heavy smokers (nondeprived CO > 55, for whom the smoking abstinence requirement may be too extreme to allow a sensitive test of our OC manipulation) and daily smokers with a nondeprived CO reading <10 PPM as this would raise concerns that they do smoke enough to be classified as a daily smoker.
I have a current neurological or psychotic disorder.
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Baseline Assessment

Participants complete a baseline breath carbon monoxide reading, odor threshold test, and self-report measures

1 hour
1 visit (in-person)

fMRI Session

Participants undergo a 60-minute fMRI scan including structural, resting state, and task-based data collection

1 week after screening
1 visit (in-person)

Behavioral Session

Participants complete behavioral tasks to assess the impact of olfactory cues on cigarette craving

1 week after fMRI session
1 visit (in-person)

Ecological Momentary Assessment (EMA)

Participants monitor cigarette cravings over a 7-day period to evaluate the impact of olfactory cues on naturally occurring craving

7 days

Follow-up

Participants are monitored for safety and effectiveness after the main study procedures

4 weeks

Treatment Details

Interventions

  • Odor Blank
  • Pleasant Odor
Trial Overview The study tests if pleasant smells can reduce cigarette cravings more effectively than neutral odors. It involves three visits: baseline assessments, fMRI scans while exposed to smoking cues and either pleasant/neutral smells, and behavioral tests on craving responses. Participants will also track their cravings for a week using their smartphones.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Pleasant OdorExperimental Treatment1 Intervention
Participants in this condition will sniff the olfactory cue they rate as both pleasant (\>5 on the 1-9 scale) and the most intense following cigarette cue exposure. If this odor is the same as their self-reported preferred e-cigarette flavor, we will choose the next most intense odor out of the odors rated as pleasant.
Group II: Odor BlankExperimental Treatment1 Intervention
Participants in this condition will sniff a neutral olfactory cue (odor blank) following cigarette cue exposure.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Trials
886
Recruited
677,000+

Findings from Research

Olfactory priming can reactivate a preference for chocolate in sated mice, suggesting that smells can trigger cravings even after a period of abstinence from palatable foods.
This study highlights the importance of olfactory cues in the relapse of maladaptive eating habits, indicating that addressing smell-related triggers could be crucial in treating eating disorders.
Olfactory priming reinstates extinguished chocolate-induced conditioned place preference.La Mela, I., Latagliata, EC., Patrono, E., et al.[2019]
In a study involving 232 abstinent smokers, pleasant olfactory cues (OCs) were found to significantly reduce cigarette cravings compared to neutral or tobacco-related odors, with the effect lasting for at least 5 minutes.
Participants with stronger autobiographical memory systems responded better to the craving-reducing effects of pleasant OCs, suggesting that these cues could be a promising tool for smoking cessation strategies.
Pleasant olfactory cues can reduce cigarette craving.Sayette, MA., Marchetti, MA., Herz, RS., et al.[2021]
Exposure to both pleasant and unpleasant odors significantly reduced the urge to smoke in nicotine-deprived smokers compared to a control odor (water), suggesting that olfactory stimuli can be a useful tool for craving reduction.
Odors that did not elicit negative facial expressions were more effective in reducing the urge to smoke, indicating that the emotional response to the odor may play a role in its effectiveness.
Effects of olfactory stimuli on urge reduction in smokers.Sayette, MA., Parrott, DJ.[2019]

References

Olfactory priming reinstates extinguished chocolate-induced conditioned place preference. [2019]
Pleasant olfactory cues can reduce cigarette craving. [2021]
Effects of olfactory stimuli on urge reduction in smokers. [2019]
Food Odours Direct Specific Appetite. [2022]
Visual Priming Influences Olfactomotor Response and Perceptual Experience of Smells. [2021]
Perceived odor, irritation, and health symptoms following short-term exposure to acetone. [2019]
Odor frequency and odor annoyance Part II: dose-response associations and their modification by hedonic tone. [2021]
Alliesthesia is greater for odors of fatty foods than of non-fat foods. [2016]
Pleasant odors and congruency: effects on approach behavior. [2019]
Olfactory stimulation curbs food cravings. [2020]
Olfactory detection thresholds and pleasantness of a food-related and a non-food odour in hunger and satiety. [2013]
Odors: appetizing or satiating? Development of appetite during odor exposure over time. [2021]
The rules of formation of the olfactory representations found in the orbitofrontal cortex olfactory areas in primates. [2019]